Vancomycin is known to cause vasodilation, and hypotension secondary t
o histamine release. We studied the actions of two forms of vancomycin
, a clinically available preparation, clinical vancomycin, and a resea
rch grade preparation, laboratory vancomycin, in the presence of an H-
1 receptor blockade and during H-2 receptor blockade with Doppler flow
probe analysis of carotid artery flow rate. Clinical vancomycin, labo
ratory vancomycin, and histamine, increased the mean carotid artery bl
ood flow from baseline in a dose-dependent manner. Diphenhydramine, H-
1 receptor antagonist, attenuated the increase in mean carotid artery
blood flow for the highest dose of clinical vancomycin and for each do
se of histamine. Famotidine, H-2 receptor antagonist, significantly at
tenuated the increase in mean carotid artery blood flow for the highes
t dose of clinical vancomycin, the two higher doses of laboratory vanc
omycin, and with each dose of histamine. Both diphenhydramine and famo
tidine attenuated the increase of mean carotid artery blood flow with
clinical vancomycin, laboratory vancomycin, and histamine. These data
suggest that the change in carotid flow produced by vancomycin, is dep
endent, in part, on either H-1 or H-2 receptor activation.